PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (Nasdaq: BJGP) today announced that it has been notified that it is the winning bidder in a sale of shares representing a majority interest in the Shanghai Rongheng Pharmaceutical Co., Ltd. (“Rongheng”) posted on the Shanghai United Assets and Equity Exchange (the “Shanghai Exchange”). This will allow Beijing Med-Pharm to enter definitive agreements with the owners of Rongheng to complete the purchase of a majority stake in the regional pharmaceutical distribution company operating from China’s largest city.
